[Treatment of senile maculopathy with etaretin].
The results of parenteral treatment with Etaretin in 40 patients (79 eyes) suffering from senile maculopathy are reported. In 84% of the cases there was a degeneration of the dry type and in 16% a disciform exudative maculopathy. The cases of dry maculopathy responded well within a floow-up period of 8 to 18 months.
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000473:pathology; D008268:Macular Degeneration / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects
D010743:Phospholipids; C038375:etaretin
Behandlung der senilen Makulopathie mit Etaretin.